Posted by on September 19, 2011 - 7:47am

Menopause has little to no impact on whether women become more susceptible to diabetes, according to a one-of-a-kind study.

Postmenopausal women had no higher risk for diabetes whether they experienced natural menopause or had their ovaries removed, according to the national clinical trial of 1,237 women at high risk for diabetes, ages 40 to 65.“In our study, menopause had no additional effect on risk for diabetes,” says study lead author Catherine Kim, M.D., M.P.H., an associate professor of internal medicine and obstetrics and gynecology at the University of Michigan Health System. “Menopause is one of many small steps in aging and it doesn’t mean women’s health will be worse after going through this transition.”

Kim and colleagues in the Diabetes Prevention Program Research Group will publish their results in the August issue of Menopause.  The findings also shed light on the impact of diet and exercise and hormone replacement therapy on the health of postmenopausal women.

Previous evidence has suggested that menopause would speed the progression to diabetes because postmenopausal women have relatively higher levels of the hormone testosterone, which is considered a risk factor for diabetes. But the recent study shows healthy outcomes for postmenopausal women.

The women in the study were enrolled in the Diabetes Prevention Program, a clinical trial of adults with glucose intolerance, meaning tests show their body’s struggle to process glucose, or blood sugar, into energy.

Glucose intolerance is often a pre-stage to diabetes, a condition common later in life and is diagnosed when the body has abnormally high levels of blood sugar. Age, weight, physical activity and family history can contribute to type 2 diabetes.

But Diabetes Prevention Program researchers have shown lifestyle intervention and the blood sugar-lowering drug metformin can prevent diabetes in those with glucose intolerance. The interventions work well in women who have gone through menopause.

Menopause is the end of monthly periods and chance for pregnancy and estrogen production by the ovaries stops. In the United States, menopause happens around age 51 or 52.

The research is considered the only menopause study that specifically analyzed the impact of diabetes on women who had natural menopause and those who had their ovaries removed. Most other studies mixed them together or excluded one group.

According to the new study, for every year 100 women were observed, 11.8 premenopausal women developed diabetes, compared to 10.5 among women in natural menopause and 12.9 cases among women who had their ovaries removed.

However for women whose estrogen production ended as a result of having their ovaries removed, and engaged in lifestyle changes, cases of diabetes were extremely low. For every year 100 of these women were observed, only 1.1 women developed diabetes.Lifestyle changes included losing 7 percent of their body weight and exercising for at least 150 minutes a week. For instance, a 180-pound postmenopausal woman would see benefits from losing 12.6 pounds.

The results among this group were surprising considering almost all of the women who had their ovaries removed were on hormone replacement therapy, a regime that women and doctors fear puts them at risk for a host of health issues. Study authors say more research is needed on the role of hormone therapy and diabetes risk.

“Physicians can be empowered to tell women that lifestyle changes can be very effective, and that menopause does not mean that they have a higher risk of diabetes,” Kim says.

Source: University of Michigan Health System

Posted by on September 17, 2011 - 9:41am

The following blog is excerpted from a Center for Disease Prevention and Control (CDC)  blog and raises important issues regarding genomic (genetic) testing.

Campaigns against public spitting in the 19th century were largely driven by concerns about the spread of tuberculosis. However, at the beginning of the 21st century, spitting seems to be making a comeback since it is a common source of DNA for testing.  Over the past few years, several companies have begun offering personal genomic tests online to the public. There have been famous images of “spit parties”, where celebrities are seen filling tubes with saliva to ship for DNA testing. Getting information on one’s genes has been promoted as fun, as part of social networking, and as a basis for improving health and preventing disease.

When it comes to spitting to improve one’s health, we say: think before you spit.  Our knowledge of the potential benefits and harms of these tests is incomplete at best.  Despite exciting research advances in genomics of common diseases, there is still much to learn about what this information means and how to use it to prevent disease. A little bit of incomplete or inaccurate information may even be harmful.

There are at least 2 key questions to consider when deciding whether personal genomic tests are worth your spit. First, how well can these tests detect or predict particular health conditions?  Most common diseases, such as diabetes, cancers, and heart disease, are caused by multiple genes and interactions with environment and behavior. Therefore, a risk estimate based only on genes is bound to be uncertain and can rapidly change based on new information. Different companies may even arrive at different interpretations of the same information. In 2010, a special undercover investigation by the Government Accountability Office found that tests by different companies of the same samples gave contradictory results. Second, can the test provide additional information that leads to better health? If the test indicates increased or decreased risk for a disease, what can be done about it? Will the test tell us more than what we know to do already?

Many interventions for reducing one’s risk for common diseases–such as smoking cessation, weight loss, increased physical activity, and blood pressure control–are beneficial regardless of a person’s genetic background. In the words of one consumer who responded to the CDC podcast on personal genomics in 2010:  “…seems one should just assume you have many health risks, then take really good care of yourself to lessen risks. Pretend you did the tests. Get ‘pretend-scared’ straight! You can then motivate yourself to keep healthy weight, exercise, reduce stress, get enough rest, consume healthy foods, avoid unhealthy habits,  enjoy hobbies & keep mind active, build friendships & family bonds…” In fact, new data from CDC  show that people who engaged in four healthy behaviors — not smoking, eating a healthy diet, getting regular physical activity, and limiting alcohol consumption- had much lower likelihoods of dying (over an 18 year period) from cancer, cardiovascular disease and other causes than those who did not engage in all four healthy behaviors.  Not smoking provides the most protection from dying early from all causes.

Several scientific studies designed to evaluate the potential impact of personal genomic information on health behavior and outcomes have been published and more are under way. Recommendations for setting scientific standards and a research agenda for personal genomics were published in 2009 by a panel convened by the Centers for Disease Control and Prevention and the National Institutes of Health.  Those recommendations for scientific evaluation still hold today.

In 2008, Dr Kari Stefansson, a leading scientist in the genetics community and founder of one of the companies that offer personal genomic tests said: “I am convinced that within five years every college-educated person in America is going to have a [genomic] profile like this. You cannot afford not having this.”  While this prediction may or may not be fulfilled based on the evolving scientific evidence, when a valid and useful test becomes available, the public health imperative is to have such tests widely available,  regardless of educational levels or other socioeconomic factors. For example, a recent national survey found that BRCA1/2 testing for breast and ovarian cancer—which is clearly beneficial for some women at high risk—is underutilized, especially among black and Hispanic women.

A very informative and inexpensive “genomic test” is available right now: family health history. An accurate, updated family health history can help healthcare providers assess the presence of many genetic conditions and whether patients and their relatives may have an increased risk for specific diseases. Family history also captures shared genetic, environmental and cultural disease risk factors.

Posted by on September 15, 2011 - 6:35am

A new Northwestern University study provides compelling evidence that human males are biologically wired to care for their offspring, conclusively showing for the first time that fatherhood lowers a man’s testosterone levels. So guys, there is no excuse for not pitching in and, ladies, this is good news if you are a new mother who could use some help with that new family addition!.

The effect is consistent with what is observed in many other species in which males help take care of dependent offspring. Testosterone boosts behaviors and other traits that help a male compete for a mate. After they succeed and become fathers, “mating-related” activities may conflict with the responsibilities of fatherhood, making it advantageous for the body to reduce production of the hormone.

“Humans are unusual among mammals in that our offspring are dependent upon older individuals for feeding and protection for more than a decade,” said Christopher W. Kuzawa, co-author of the study and associate professor of anthropology in the Weinberg College of Arts and Sciences. “Raising human offspring is such an effort that it is cooperative by necessity, and our study shows that human fathers are biologically wired to help with the job.”

Past studies showing that fathers tend to have lower testosterone levels were small and not conclusive regarding whether fatherhood diminished testosterone or whether men with low testosterone in the first place were more likely to become fathers. The new study takes a novel approach by following a large group of men who were not fathers and seeing whether their hormones changed after becoming fathers.

“It’s not the case that men with lower testosterone are simply more likely to become fathers,” said Lee Gettler, a doctoral candidate in anthropology at Northwestern and co-author of the study. “On the contrary, the men who started with high testosterone were more likely to become fathers, but once they did, their testosterone went down substantially. Our findings suggest that this is especially true for fathers who become the most involved with child care.”

The new study’s findings also suggest that fathers may experience an especially large, but temporary, decline in testosterone when they first bring home a newborn baby. “Fatherhood and the demands of having a newborn baby require many emotional, psychological and physical adjustments,” Gettler said. “Our study indicates that a man’s biology can change substantially to help meet those demands.”

The authors also suggest that their findings may provide insight into one reason why single men often have poorer health than married men and fathers. “If fathers have lower testosterone levels, this might protect them against certain chronic diseases as they age,” Kuzawa said.

The study followed a group of 624 males aged 21.5 to 26 years old for 4.5 years in the Philippines.

“Longitudinal Evidence That Fatherhood Decreases Testosterone in Human Males” was published Sept. 12, 2011, in the Proceedings of the National Academy of Sciences.

Author:  Hilary Hurd Anyaso,  law and social sciences editor, Northwestern Newscenter.

Posted by on September 13, 2011 - 6:55am

No bones about it:  eating prunes helps prevent fractures and osteoporosis.   When it comes to improving bone health in postmenopausal women — and people of all ages, actually — a Florida State University researcher has found a simple, proactive solution to help prevent fractures and osteoporosis: eating dried plums.

“Over my career, I have tested numerous fruits, including figs, dates, strawberries and raisins, and none of them come anywhere close to having the effect on bone density that dried plums, or prunes, have,” said Bahram H. Arjmandi, of  Florida’s chairman of the Department of Nutrition, Food and Exercise Sciences in the College of Human Sciences. “All fruits and vegetables have a positive effect on nutrition, but in terms of bone health, this particular food is exceptional.”

Arjmandi and a group of researchers from Florida State and Oklahoma State University tested two groups of postmenopausal women. Over a 12-month period, the first group, consisting of 55 women, was instructed to consume 100 grams of dried plums (about 10 prunes) each day, while the second — a comparative control group of 45 women — was told to consume 100 grams of dried apples. All of the study’s participants also received daily doses of calcium (500 milligrams) and vitamin D (400 international units).

The group that consumed dried plums had significantly higher bone mineral density in the ulna (one of two long bones in the forearm) and spine, in comparison with the group that ate dried apples. This, according to Arjmandi, was due in part to the ability of dried plums to suppress the rate of bone resorption, or the breakdown of bone, which tends to exceed the rate of new bone growth as people age.

The group’s research, “Comparative Effects of Dried Plum and Dried Apple on Bone in Post Menopausal Women,” was published in the British Journal of Nutrition.  In the United States, about 8 million women have osteoporosis because of the sudden cessation of ovarian hormone production at the onset of menopause. What’s more, about 2 million men also have osteoporosis.

“In the first five to seven postmenopausal years, women are at risk of losing bone at a rate of 3 to 5 percent per year,” Arjmandi said. “However, osteoporosis is not exclusive to women and, indeed, around the age of 65, men start losing bone with the same rapidity as women.”

Arjmandi encourages people who are interested in maintaining or improving their bone health to take note of the extraordinarily positive effect that dried plums have on bone density.

“Don’t wait until you get a fracture or you are diagnosed with osteoporosis and have to have prescribed medicine,” Arjmandi said. “Do something meaningful and practical beforehand. People could start eating two to three dried plums per day and increase gradually to perhaps six to 10 per day. Prunes can be eaten in all forms and can be included in a variety of recipes.”

Source: Florida State University

Posted by on September 11, 2011 - 6:49am

Women and men experience pain, particularly chronic pain, very differently. The ability of some opioids (painkillers that work similar to opium/morphine) to relieve pain also differs between sexes. While it has been recognized since the mid-nineties that some narcotic analgesics are more effective in women than men, the reason for this difference was largely unknown.

Narcotic painkillers (analgesics)  decrease pain by activating opioid receptors, which are located on nerves that transmit painful sensations. There are 4 major subgroups of opioid receptors:  delta, kappa, mu and Nociceptin, and each is involved in controlling different functions of the brain. Since levels of mu, delta, and kappa opiate receptors - the three main types of opioid receptor in the brain and spinal cord - are not thought to differ dramatically in men and women, it was difficult to understand why the effectiveness of some painkillers is dependent on sex.

Now, research supported by the National Institute of Drug Abuse (NIDA) has revealed that the same major types of opioid receptor interact differently, depending on sex. The spinal cord of female laboratory animals was found to contain almost five times more kappa-mu heterodimer (a complex formed by two different macromolecules bound together, e.g, mu-opioid and kappa-opioid receptor) than the spinal cord of male animals. Furthermore, the amount of mu-kappa heterodimer in the spinal cord of the females was about four times higher when their levels of estrogen and progesterone were at their peak. Subsequently, researchers found that both estrogen and progesterone are critical for the formation of mu-kappa opioid receptor heterodimers.

The discovery of a mu-kappa opioid receptor complex that is more prevalent in the spinal cord of females than males and that is synchronized with the ebb and flow of ovarian hormones could explain why drugs used to treat pain, such as pentazocine, nalbuphine, and butorphanol - which primarily act on mu-opioid and kappa-opioid receptors - are more effective in women than men. The activation of the kappa-opioid receptor within the kappa-mu-opioid receptor complex could provide a mechanism for recruiting the pain-relieving functions of spinal kappa-opioid receptors without also activating their pain-promoting functions.

The research by Drs. Gintzler, Liu, and Chakrabart from State University of New York (SUNY) Downstate Medical Center, suggests that kappa-mu opioid receptor heterodimers could function as a molecular switch that shifts the action of kappa-opioid receptors and endogenous chemicals that act on them from pain-promoting to pain-alleviating. Kappa-mu opioid receptor heterodimers could serve as a novel molecular target for pain management in women.

Dr. Gintzler's research suggests that physicians should take the stage of the menstrual cycle into account before deciding which drugs to prescribe to treat pain in women. While some drugs might be very effective in treating pain at times when estrogen and progesterone levels are high, they could heighten pain when levels are low. "This consideration could become even more critical in managing pain in postmenopausal and elderly women," said Dr. Gintzler. "Further research is needed to flesh out these possibilities."

Article References:  The Journal of Neuroscience August 17, 2011 edition.

 

 

Posted by on September 9, 2011 - 7:07am

A new simulation model predicts weight changes with varying diets and exercise plans.  Researchers at the National Institutes of Health (NIH) have created a mathematical model — and an accompanying online weight simulation tool — of what happens when people of varying weights, diets and exercise habits try to change their weight. The findings challenge the commonly held belief that eating 3,500 fewer calories — or burning them off exercising — will always result in a pound of weight loss.

Instead, the researchers’ computer simulations indicate that this assumption overestimates weight loss because it fails to account for how metabolism changes. The computer simulations show how these metabolic changes can significantly differ among people. Findings are published Aug. 26 in a Lancet issue devoted to obesity.

However, the computer simulation of metabolism is meant as a research tool and not as a weight-loss guide for the public. The computer program can run simulations for changes in calories or exercise that would never be recommended for healthy weight loss. The researchers hope to use the knowledge gained from developing the model and from clinical trials in people to refine the tool for everyone.

“This research helps us understand why one person may lose weight faster or slower than another, even when they eat the same diet and do the same exercise,” said Kevin Hall, Ph.D., an obesity researcher and physicist at the NIH, National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK)  and the paper’s first author. “Our computer simulations can then be used to help design personalized weight management programs to address individual needs and goals.”

The online simulation tool based on the model enables researchers to accurately predict how body weight will change and how long it will likely take to reach weight goals based on a starting weight and estimated physical activity. The tool simulates how factors such as diet and exercise can alter metabolism over time and thereby lead to changes of weight and body fat.

To test the model, the researchers compared predicted weight changes to actual changes in people. For example, the team found that people’s bodies adapt slowly to changes in dietary intake. They also found heavier people can expect greater weight change with the same change in diet, though reaching a stable body weight will take them longer than people with less fat.

The model also points to a potential simplified method to approximate weight loss in an average overweight person. An adult who has a body mass index (a measure of a person’s weight in relation to his or her height) between 25 and 29.9 is considered overweight. One example: For every pound you want to lose, permanently cut 10 calories from your current intake per day. At that rate, it will take about one year to achieve half of the total weight loss, and almost all of the weight loss will have occurred by three years. This calculation shows how long it takes to achieve a weight-loss goal for a single permanent change of diet or exercise. Researchers can use the web simulation tool to plan for a phase of more-rapid weight loss followed by a weight maintenance phase. People should consult with their physician prior to embarking on a diet plan.

“This research illustrates how the interdisciplinary skills of NIH scientists, like a physicist doing obesity research, can help lead to innovative ways to test, understand and treat a major public health epidemic,” said NIDDK Director Griffin P. Rodgers, M.D. “Advancing research from the laboratory to the bedside enables us to make the discoveries that can better people’s lives.”

 

Posted by on September 7, 2011 - 6:06am

Soy supplements do not help women in menopause, according to the findings of a two-year, $3 million study conducted at the Miller School of Medicine’s Osteoporosis Center. The study was funded by the National Institutes of Health to determine if the widely popular product could preserve bone health and ease symptoms in the first years of menopause. The results show that, contrary to popular belief, soy isoflavone supplements neither prevent bone loss nor reduce menopausal symptoms.

The findings of the SPARE Study, which stands for Soy Phytoestrogens As Replacement Estrogen, were published in the August 8 issue of the Archives of Internal Medicine.

“The consumption of soy foods and soy supplements has dramatically increased in the last few years, particularly among women who start taking various over-the-counter products around the time of menopause, believing that these products will provide all the benefits and none of the risks of menopausal hormone therapy,” said Silvina Levis, professor of medicine, director of the Osteoporosis Center, and principal investigator and lead author of the study. “Our study showed that soy phytoestrogen tablets do not provide any benefit, but fortunately do not cause any apparent harm either. The participants had the same rates of bone loss and menopausal symptoms, whether they were taking soy tablets or placebo tablets (sugar pills). The women on the soy tablets actually had more constipation and abdominal bloating.”

The participants, women aged 45 to 60 and within five years of menopause, were randomly assigned, in equal proportions, to receive either daily soy isoflavone tablets or the placebo and were not aware of which they were taking.

The women were followed for two years and underwent a bone density test (DXA) at the beginning and the end of the study to measure the rate of bone loss. The study showed no meaningful difference in the rate of bone loss between those taking the soy tablets and those taking the placebo. Additionally, those women taking the soy supplement reported no measurable improvement in the number or severity of menopausal symptoms such as hot flashes or in vaginal cytology or cholesterol levels.

While the study is not an endorsement of hormone therapy, it objectively demonstrated that women who take soy isoflavone supplements will not enjoy any clinical benefits.

Source:  University of Miami Veritas

Posted by on September 5, 2011 - 6:05am

Over the years, we hear about "cancer clusters" or a growing rise in behavioral conditions like autism and advocates and families want answers.  Is it our genes or something in the environment?   This concern often leads to an epidemiological study that tracks these diseases over time.   But sometimes, despite the time, effort and expense, no definitive causation is established.  This  can be frustrating to families facing these conditions and the scientists who are looking for answers.  This is the conundrum of  nature vs. nurture.

The problem is that the causes of  particular diseases may be part of both.  For example, it is not uncommon to have the explanation of a disease presented as 25% genetic (nature) and 75% environmental (nurture), adding up to 100% (like slices of a whole pie).

However, what we have learned from gene-disease association studies is that in reality, human disease is rarely a product of such simple and clearly defined relationship.  Causation of human disease is not about nature OR nurture but more about nature AND nurture.   Gene-environmental  interactions underlie almost all human diseases. The Center for Disease control (CDC), explains this on a recent blog.

Most common diseases such as coronary heart disease, cancer, and diabetes are caused by modifiable environmental risk factors such as smoking, diet and lack of exercise.   However, if you have a family history of one of these conditions, your risk will likely be higher than someone without a family history.    Even though the human genome has been uncovered, we do not yet have the tools to quantify or even guess at the vast number of variations that can exist.

Rather than think about slices of pie, the CDC suggests we look at a different metaphor:   vegetable stew!   The genes are represented by the different combinations of vegetables used, and the environment can be the amount of time the stew is cooked, the temperature, what kind of pot was used (aluminum vs. cast iron).   Taking this further, there are different varieties of corn, tomatoes, herbs and beans and the spices used can change the taste immensely.  Once assembled, the ingredients blend and cook to produce a combined but unique flavor.    Biologic processes function in a similar way, as genes respond to constantly changing environment.

As scientists continue to work with the human genome, there may come a day when we can learn more about our personal vegetable stew recipe.

Posted by on September 3, 2011 - 7:41am

Protect your daughter from cervical cancer by getting her the HPV vaccine. It takes 3 shots to complete the series, so make sure she gets them all to be protected.
It's easy to get very busy with school, activities, work, and all of the juggling that parents of preteens and teens do every day. For the sake of your daughter's health, take the time to get her the life-saving HPV vaccine to protect against cervical cancer. Every year in the U.S., about 12,000 women are diagnosed with cervical cancer, and 4,000 die. If we protect girls now, we could reduce disease and cancer due to HPV.   About 20 million people, most in their late teens and early 20s, are infected with HPV, the type of virus that causes cervical cancer. That's why it's important to protect preteen and teen girls early through vaccination.

The HPV vaccine is safe and effective and is given in a series of 3 shots over about a six-month period. The second shot is given 1 or 2 months after the first, and the third shot is given 6 months after the first shot. It is very important to complete all of the shots to be fully protected. 35 million doses of HPV vaccine have been safely given to girls across the country.

If your daughter is age 11 years or older, the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), and the Society for Adolescent Health and Medicine (SAHM) recommend you vaccinate now to protect her against cervical cancer.    If your daughter is older than 11 or 12 and has not started these shots, it's not too late.

Posted by on September 1, 2011 - 7:07am

Current cigarette smokers have a higher risk of bladder cancer than previously reported, and the risk in women is now comparable to that in men, according to a study by scientists from the National Cancer Institute (NCI) . This latest study uses data from over 450,000 participants in the NIH-AARP Diet and Health Study, a questionnaire-based study that was initiated in 1995, with follow-up through the end of 2006.

While previous studies showed that only 20 to 30 percent of bladder cancer cases in women were caused by smoking, these new data indicate that smoking is responsible for about half of female bladder cancer cases – similar to the proportion found in men in current and previous studies.  The increase in the proportion of smoking-attributable bladder cancer cases among women may be a result of the increased prevalence of smoking by women, so that men and women are about equally likely to smoke, as observed in the current study and in the U.S. population overall, according to surveillance by the CDC. The majority of the earlier studies were conducted at time periods or in geographic regions where smoking was much less common among women.

The researchers found that the amount of risk brought on by smoking, called excess risk, was higher in this study than in previously reported. “Current smokers in our study had a fourfold excess risk of developing bladder cancer, compared to a threefold excess risk in previous studies. The stronger association between smoking and bladder cancer is possibly due to changes in cigarette composition or smoking habits over the years,” said study author Neal Freedman, Ph.D., in NCI’s Division of Cancer Epidemiology and Genetics (DCEG). “Incidence rates of bladder cancer in the United States have been relatively stable over the past 30 years, despite the fact that smoking rates have decreased overall. The higher risk, as compared to studies reported in the mid-to-late 1990s, may explain why bladder cancer rates haven’t declined.”

Although there have been reductions in the concentrations of tar and nicotine in cigarette smoke, there have been apparent increases in the concentrations of certain carcinogens associated with bladder cancer. A 2009 NCI/DCEG study was the first to suggest a higher risk for smoking-induced bladder cancer than previously reported.  That report, based on data from the New England Bladder Cancer Study, found that the association between cigarette smoking and risk of bladder cancer appeared to be stronger than it was in the mid-1990s. The results of the new study confirm the 2009 report.

In the current study, former smokers were twice as likely to develop bladder cancer as never smokers, and current smokers were four times more likely than those who never smoked. As with many other smoking-related cancers, smoking cessation was associated with reduced bladder cancer risk. Participants who had been smoke-free for at least 10 years had a lower incidence of bladder cancer compared to those who quit for shorter periods of time or who still smoked.

“Our findings provide additional evidence of the importance of preventing smoking initiation and promoting cessation for both men and women,” said senior author Christian Abnet, Ph.D., also from DCEG. “Although the prevalence of cigarette smoking has declined, about 20 percent of the U.S. adult population continues to smoke.”

Even though smoking carries the same risk for men and women, men are still about four times more likely to be diagnosed with bladder cancer.  These results, as well as those from previous studies, suggest that difference in smoking rates explain only part of the higher incidence rates in American men.  The researchers suggest that occupational exposures, as well as physiologic differences, may contribute to the gender disparity.

In 2011, approximately 69,250 people will be diagnosed with bladder cancer in the United States, and 14,990 will die from the disease.

The report was published on Aug. 16, 2011, in the Journal of the American Medical Association.

Pages